The team at Isomerase Therapeutics are delighted to announce that they are proud winners of a Queen’s Award for Enterprise in International Trade 2017.
The Queen’s Award is the most prestigious corporate achievement that any UK business can attain and is a seal of approval for outstanding performance.
Dr Matt Gregory (CEO) and Dr Steven Moss (CTO) co-founded and have managed the company from its formation in 2012 to its current position. The company's overseas sales have grown by over 600% during the last three years with strong relationships built with companies across the globe. It employs over 20 highly skilled staff working from the company’s facility at Chesterford Research Park, near Cambridge. The team at Isomerase works with partners to help them discover and develop Microbial Natural Products.
Dr Matt Gregory stated “The Queen’s Award reflects the exceptional science we do and our commitment to innovation, investment in UK science and in global collaborations.”
The Queen will hold a reception at Buckingham Palace later in the year which will be attended by representatives of Isomerase Therapeutics.